Sleep Apnea, Obstructive Clinical Trial
Official title:
A 1 Year Open Label, Flexible Dosage Extension Study to Assess the Safety and Continued Effectiveness of PROVIGIL® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome
The primary objective of the study is to evaluate the safety and tolerability of treatment with PROVIGIL in children and adolescents with excessive sleepiness (ES) associated with narcolepsy or OSAHS (obstructive sleep apnea/hypopnea), when administered for up to 12 months. Safety and tolerability will be evaluated throughout the study by means of adverse event information, clinical laboratory test results, vital signs measurements, and body weight and height measurements; quarterly physical examination findings; and 12 lead electrocardiograph (ECG) evaluations at the end of the study. In addition, the cognitive and behavioral effects of PROVIGIL will be assessed quarterly as measured by the Child Behavior Checklist for Ages 6-18 (CBCL/6-18), a brief psychiatric interview, and the Kaufman Brief Intelligence Test (KBIT 2).
PROVIGIL is a registered trademark of Genelco, S.A., licensed to Cephalon, Inc. ;
Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT03605329 -
Evaluation of the Severity of Cardiovascular Autonomic Neuropathy in Type 1 Diabetic Patients With OSAS
|
N/A | |
| Completed |
NCT04912635 -
Evaluation of a Health Dashboard Intervention to Improve Engagement With CPAP Therapy in PAP-Naïve Patients: Project Neo
|
N/A | |
| Not yet recruiting |
NCT05939934 -
Impact of the Mandibular Advancement Device on Sleep Apnea During CPAP Withdrawal
|
N/A | |
| Enrolling by invitation |
NCT02290236 -
Monitored Saturation Post-ICU
|
N/A | |
| Terminated |
NCT02269774 -
Origin of Premature Atrial Beats Induced by Simulated Obstructive Sleep Apnea
|
N/A | |
| Completed |
NCT02088723 -
Testing the Elevation as Sleep Apnea Treatment
|
N/A | |
| Completed |
NCT02261857 -
3D-Printed CPAP Masks for Children With Obstructive Sleep Apnea
|
Early Phase 1 | |
| Completed |
NCT01943708 -
Novel Auto-continuous Positive Airway Pressure (CPAP) Validation
|
Phase 3 | |
| Completed |
NCT01181570 -
Efficacy and Safety of Adalimumab in Patients With Psoriasis and Obstructive Sleep Apnea
|
Phase 4 | |
| Completed |
NCT00273754 -
The Effect of Caffeine on Postextubation Adverse Respiratory Events in Children With Obstructive Sleep Apnea (OSA).
|
Phase 2 | |
| Recruiting |
NCT02166879 -
Undetected Sleep Apnea in the Postanesthesia Acute Care Unit (PACU)
|
||
| Recruiting |
NCT04963192 -
Integrated Management of Chronic Respiratory Diseases
|
N/A | |
| Completed |
NCT05056766 -
How Does the Clinical and Paraclinical Efficacy of an Oral Appliance Evolved According to Propulsion: Control With Each mm of Advancement
|
||
| Completed |
NCT04846400 -
Pilot Study of a Self-Supporting Nasopharyngeal Airway in Hypotonia
|
N/A | |
| Recruiting |
NCT04314492 -
Intracapsular Tonsillectomy in the Treatment of Obstructive Sleep Apnea in Adults
|
N/A | |
| Completed |
NCT05175287 -
OSA (oRisk of Obstructive Sleep Apnea and Traffic Accidents Among Bus Drivers in Ecuador: is There a Significant Association
|
||
| Active, not recruiting |
NCT03431038 -
Cross-sectional Study of Prevalence Rate of Abdominal Aortic Aneurysm in OSAHS Patients From BTCH
|
N/A | |
| Enrolling by invitation |
NCT03075787 -
Cardiovascular Variability and Heart Rate Response Associated With Obstructive Sleep Apnea
|
N/A | |
| Completed |
NCT03300037 -
HYpopnea and Apnea Detection and Treatment Performance of a New cardiOreSpiratory Holter Monitor
|
N/A | |
| Recruiting |
NCT06097949 -
AcuPebble to Remotely Monitor Patients With OSA on CPAP Therapy
|